Empliciti and Ibuprofen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Empliciti (elotuzumab) and Ibuprofen (ibuprofen). Common drug interactions include decreased appetite among females and dysphonia among males.

The phase IV clinical study analyzes what interactions people have when they take Empliciti and Ibuprofen. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Empliciti?

Empliciti has active ingredients of elotuzumab. eHealthMe is studying from 2,545 Empliciti users. Check the latest studies of Empliciti.

What is Ibuprofen?

Ibuprofen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,270 Ibuprofen users. Check the latest studies of Ibuprofen.



On Jul, 04, 2026

19 people who take Empliciti and Ibuprofen together, and have interactions are studied.

Empliciti and Ibuprofen drug interactions.

What are the common drug interactions of Empliciti and Ibuprofen, by gender? *:

female:

  1. Decreased appetite
  2. Fatigue (feeling of tiredness)
  3. Immune system disorder
  4. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  5. Plasma cell myeloma (cancer that begins in plasma cells)
  6. Pneumonia
  7. Thrombocytopenia (decrease of platelets in blood)

male:

  1. Dysphonia (speech disorder attributable to a disorder of phonation)
  2. Fatigue (feeling of tiredness)
  3. Drug ineffective
  4. Dyspepsia (indigestion)
  5. Flatulence (flatus expelled through the anus)
  6. Gingival disorder (gum disease)
  7. Influenza
  8. Muscle spasms (muscle contraction)
  9. Myalgia (muscle pain)
  10. Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Empliciti and Ibuprofen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  2. Pneumonia
  3. Thrombocytopenia (decrease of platelets in blood)

60+:

  1. Pneumonia
  2. Arthralgia (joint pain)
  3. Nausea (feeling of having an urge to vomit)
  4. Night sweats (sweating in night)
  5. Peripheral swelling
  6. Plasma cell myeloma (cancer that begins in plasma cells)
  7. Pyrexia (fever)
  8. Chills (felling of cold)
  9. Dyspepsia (indigestion)
  10. Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 19 people, 100.00%
  2. Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 1 person, 5.26%
  3. Hypersensitivity: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Empliciti and Ibuprofen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Empliciti and Ibuprofen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Empliciti:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ibuprofen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Empliciti and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ibuprofen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on elotuzumab and ibuprofen (the active ingredients of Empliciti and Ibuprofen, respectively), and Empliciti and Ibuprofen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: